Key facts
- This page summarizes Lord Ara Darzi's Form 4 filing for Evelo Biosciences, Inc..
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 Jun 2022, 16:38.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Additional SEC filing notes
Footnote F1
The option vests on the earlier of June 9, 2023 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.
Footnote F2
The option vests on the earlier of June 10, 2023 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.